Authors:
GAZITT Y
ROTHENBERG ML
HILSENBECK SG
FEY V
THOMAS C
MONTEGOMREY W
Citation: Y. Gazitt et al., BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO PACLITAXEL, BUTNOT GEMCITABINE, IN MULTIPLE-MYELOMA CELLS, International journal of oncology, 13(4), 1998, pp. 839-848
Citation: Y. Gazitt et al., BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO DEXAMETHASONE, BUT NOT MELPHALAN, IN MULTIPLE-MYELOMA CELLS, International journal of oncology, 13(2), 1998, pp. 397-405
Authors:
GAZITT Y
ROTHENBERG M
FEY V
MONTGOMERY W
ALVAREZ R
Citation: Y. Gazitt et al., GEMCITABINE (GEM) IS A PANCYTOTOXIC DRUG FOR VARIOUS MULTIPLE-MYELOMA(MM) CELL-LINES, WHEREAS TAXOL (TAX) CYTOTOXICITY IS DEPENDENT ON THEEXPRESSION OF BCL-2, Blood, 90(10), 1997, pp. 1455-1455